Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system
Veterinary Research volume 51, Article number: 41 (2020)
Eimeria tenella has emerged as valuable model organism for studying the biology and immunology of protozoan parasites with the establishment of the reverse genetic manipulation platform. In this report, we described the application of CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 (endonuclease) system for efficient genetic editing in E. tenella, and showed that the CRISPR/Cas9 system mediates site-specific double-strand DNA breaks with a single guide RNA. Using this system, we successfully tagged the endogenous microneme protein 2 (EtMic2) by inserting the red fluorescent protein into the C-terminal of EtMic2. Our results extended the utility of the CRISPR/Cas9-mediated genetic modification system to E. tenella, and opened a new avenue for targeted investigation of gene functions in apicomplexan parasites.
Introduction, methods, and results
Members of the Eimeria genus are principal causative agents of coccidiosis in a wide range of livestock and birds . With its distinct biology and immunology, the Eimeria parasite also holds promise as a model organism for protozoan research. The establishment of transient transfection and stable selection protocols has greatly enhanced dissection of several biological and immunological properties in this parasite [2, 3]. Nevertheless, the absence of an effective gene editing system has left many questions about functions of Eimeria’s unique genes unanswered.
The prokaryotic CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 (endonuclease Cas9) system is a recently developed tool for genetic editing in a variety of organisms [4, 5], including protozoan parasites Toxoplasma, Plasmodium, and Trypanosoma [6,7,8,9]. Due to lack of efficient in vitro tissue culture model and an effective selection marker, the technical capability for genetic modification of Eimeria has lagged behind for that of Toxoplasma and Plasmodium. The CRISPR/Cas9 system introduces site-specific double-strand DNA breaks (DSBs) with endonuclease Cas9 in a target sequence that is homologous to the single guide RNA (sgRNA). Subsequent repair of the DSBs is carried out by the host cell through either non-homologous end-joining pathway (NHEJ), leading to insertion and deletion mutations in the targeted genes, or homologous direct repair (HDR) in the presence of a DNA donor template. In this study, we present experimental evidence that the CRISPR/Cas9 system is also useful for targeted gene modification in Eimeria.
A circular plasmid with nlsSpCas9-EYFP expression cassette was constructed (Figure 1A), with the nlsSpCas9-EYFP driven by histone protein 4 (His4) promoter. The nuclear localization sequence (nls) of His4 was introduced into the N-terminal of Streptococcus pyogenes (SpCas9) to target the nucleus of the endonuclease SpCas9. SpCas9 was also tagged with enhanced yellow fluorescent protein (EYFP) gene for visualization of the SpCas9 expression signal in subcellular sites of Eimeria. Using this strategy, we found that the proportion of EYFP positive sporozoites was approximately 1.0 × 10−3 24 h after transient transfection with the circular plasmid and in vitro culture according to the previous methods [10, 11]. The signals of EYFP and DAPI (4′,6-diamidino-2-phenylindole) were co-localized in the nucleus of sporozoites (Figure 1A). These results demonstrated that the nls of His4 efficiently localized SpCas9 to the nucleus.
RNA polymerase III promoters, such as human U6 promoter, have been widely utilized to drive guide RNA expression in eukaryotes . We identified two RNA polymerase III U6 promoter candidates (EtU6-1 and EtU6-2; Additional file 1) in E. tenella genome by alignment with Plasmodium (the genomic location of EtU6-1 and EtU6-2 were HG673812: 317 896..318 493 and HG673812: 318 728..319 328 in ToxoDB, respectively). To confirm the site-specific DSBs by SpCas9 in a target sequence that is homologous to sgRNA in E. tenella, we conducted a “function lost” experiment of the target gene (EYFP). In brief, we constructed a double cassette plasmid (pHis-Cas9-sgRNA-EYFP): one is SpCas9 expression cassette regulated by His4 promoter and nls, the other is EYFP specific gRNA (5′-GCATGTGATCGCGCTTCTCGT-3′) cassette driven by EtU6-1 promoter (Figure 1B). The EtER sporozoites (1.0 × 107), a recombinant E. tenella line with stable expression of EYFP and red fluorescent protein (RFP) , were transfected with circular plasmid of pHis-Cas9-sgRNA-EYFP (10.0 μg) using the AMAXA nucleofection system (program U033) and then inoculated to the chicks (each bird receiving a total number of 1.0 × 106 transfected sporozoites) via the cloacal route. We found that the EYFP expression was lost with a ratio of 1.2 × 10−3 in the first-generation progeny of sporulated oocysts (Figure 1B). We propagated the population (EtER mutation, mEtER) after adverse selection, selected fluorescence negative population by fluorescence-activated cell sorting (FACS). The EYFP positive oocysts of mEtER was reduced to 89.5% after four generations’ selection (Figure 1B). These results suggested that CRISPR/Cas9 mediated site-specific DSBs of eyfp are repaired by NHEJ in the absence of donor DNA template. To confirm this observation, a T7 endonuclease I (T7EI) assay was performed to detect the mutation of eyfp after endogenous cleavages . As T7EI recognizes and cleaves mismatched DNA, cruciform DNA structures, Holliday structures or junctions, heteroduplex DNA, and nicked double-stranded DNA, it enables detection of Cas9 induced mutations. In this study, genomic DNA of mEtER or EtER was amplified with T7F (5′-AGCAGCACGACTTCTTCAAGTCC-3′) and T7R (5′-CTTGGAGCCGTACTGGAACTG-3′) primers (Figure 1B). The PCR product (300 ng/sample) was denatured, reannealed, and digested with T7 endonuclease I (New England BioLabs) following the manufacturer’s instructions, which cleaves mismatched heteroduplex DNA. The reaction was analyzed by denatured PAGE. We detected a specific band of eyfp cleavage after silver staining in the sample of mEtER (Figure 1C). These results demonstrated that SpCas9 expressed by E. tenella efficiently mediated targeted gene cleavage guided by sgRNA, and that EtU6-1 promoter efficiently driven sgRNA production.
Next, we tagged microneme protein 2 (EtMic2) with a red fluorescent protein (RFP) using CRISPR/Cas9 system to investigate whether this system could mediate endogenous gene modification in Eimeria. In this experiment, a donor fragment and a SpCas9 and sgRNA (target at 3′ terminal of EtMic2 gene, sequence information: 5′-GGCGTCTCGATTGTGAGAGC-3′) producing plasmids were constructed. The following four DNA fragments: left homologous arm, rfp-3′Act , EtSAG13 promoter-TgDHFR , and right homologous arm were ligated according to the instruction of HiFi DNA Assembly Master Mix kit (New England BioLabs) to generate the donor fragment (Figure 2A; Additional file 1). The E. tenella sporozoites (1.0 × 107) were co-transfected with the donor fragment (10.0 μg) and the circular plasmid (2.0 μg), which produce SpCas9 and sgRNA. The transfected sporozoites were inoculated into five 1-week-old chicks via the cloacal route. The chicks were fed with pyrimethamine (150 mg/kg) containing diet. We detected RFP positive oocysts with a ratio of 2.1 × 10−4 in the progeny of the first generation (Figure 2B). The RFP positive population (EtMic2-RFP) was increased by 25.8% after three generations’ selection with FACS and pyrimethamine. To determine if the EtMic2 are accurately tagged with RFP as predicted, PCR and indirect immunofluorescent assay (IFA)  were performed. We found specific bands after PCR amplification from the genomic DNA of EtMic2-RFP (Figure 2C). And the RFP and EtMic2 were perfectly colocalized in the microneme of EtMic2-RFP sporozoites (Figure 2D). These results demonstrated that the CRISPR/Cas9 system efficiently mediates target gene break and repair by HDR and that the system mediates endogenous gene modification in Eimeria.
Exhibiting distinct biology and immunology, Eimeria represents a model organism for experimental study of apicomplexan parasites. Although reverse genetic technologies for the Eimeria parasite are well developed [10, 11, 16], the targeting of specific loci is limited by the fact that recombination tends to occur by nonhomologous integration of foreign DNA into the chromosome in apicomplexan parasites [17, 18]. This makes it desirable to develop an alternative method for precise gene targeting in Eimeria.
The prokaryotic CRISPR/Cas9-based genome editing system is a versatile, widely adopted tool for genetic editing in biological organisms, including Caenorhabditis elegans , zebrafish , and mammalian cell . The CRISPR/Cas9 system relies on endonuclease Cas9 expression in the nucleus and spatial conformation of sgRNA for producing site-specific DSBs. As shown in this report, with the capability to knock-out (KO) and knock-in (KI) E. tenella genes (e.g., EYFP gene disruption and EtMic2 tagging with RFP), the CRISPR/Cas9 system offers a valuable approach for genetic manipulation and functional study of apicomplexan parasites.
While the two EtU6 promoters, EtU6-1 and EtU6-2, are capable of driving sgRNA production in the primary study (data not shown), there is no significant difference in efficiency between the two promoters. So, only EtU6-1 was examined here to reduce unnecessary repetitive experiments. As shown above, nls of His4 and U6 promoters (i.e., EtU6-1 promoter) of E. tenella readily localize SpCas9 to the nucleus and produce sgRNA (Figure 1B), and the DSBs could be repaired by HDR in the presence of a DNA donor template (Figure 2), despite the fact that the efficacy in Eimeria appears much lower than that in T. gondii (~20 to 30%) or Plasmodium spp. (~20%) [7, 8]. Low transfection (especially co-transfection) efficiency may be one of the reasons for the low genetic editing efficacy of Eimeria parasite using the CRISPR/Cas9 system. Therefore, further optimization of the transfection system is crucial for improving the effectiveness of gene modification in Eimeria .
Most of the selectable marker genes used for T. gondii are unsuitable for selection of stable transformants in Eimeria, owing to the following restrictions, including: (1) the cost of the reagent, like rapamycin analog Shield-1, is prohibitive for identifying stable transfection of Eimeria in an in vivo selection system; and (2) some selectable marker genes only work in specific recipient strains of Toxoplasma, like TATi and hxgprt-. Despite these restrictions, FACS and pyrimethamine selection protocols have been successfully developed for Eimeria. Further refinement of selection system is clearly imperative for improved genetic manipulation of Eimeria.
NHEJ is the preferred mechanism for insertion of foreign DNA into the genome of T. gondii, not homologous integration . No direct evidence is available yet as Eimeria’s preference for insertion of foreign DNA (NHEJ or homologous integration). In view of previous findings that foreign DNA with ~1000 bp homologous fragments are randomly inserted at different sites in the genome of recombinant Eimeria [11, 13], and current evidence of precise integration of foreign DNA, NHEJ may be the preferred mechanism for insertion of foreign DNA into the genome of Eimeria just like Toxoplasma. To further enhance the efficient in genetic editing of Eimeria, inactivation of the NHEJ pathway, such as knocking out the critical component KU80 will likely increase the efficiency of homologous recombination, thus improving genetic editing in Eimeria.
In conclusion, we successfully developed the CRISPR/Cas9 system in Eimeria, which will accelerate gene function studies in Eimeria and apicomplexan parasites.
clustered regularly interspaced short palindromic repeat
double-strand DNA breaks
single guide RNA
homologous direct repair
Streptococcus pyogenes endonuclease Cas9
nuclear localization sequence
histone protein 4
enhanced yellow fluorescent protein
red fluorescent protein
microneme protein 2 of E. tenella
a transgenic E. tenella line expressing EYFP and RFP
fluorescence-activated cell sorting
Chapman HD, Barta JR, Blake D, Gruber A, Jenkins M, Smith NC, Suo X, Tomley FM (2013) A selective review of advances in coccidiosis research. Adv Parasitol 83:93–171
Qin M, Liu XY, Tang XM, Suo JX, Tao GR, Suo X (2014) Transfection of Eimeria mitis with yellow fluorescent protein as reporter and the endogenous development of the transgenic parasite. PLoS One 9:e114188
Tang X, Suo J, Li C, Du M, Wang C, Hu D, Duan C, Lyu Y, Liu X, Suo X (2018) Transgenic Eimeria tenella expressing profilin of Eimeria maxima elicits enhanced protective immunity and alters gut microbiome of chickens. Infect Immun 86:e00888-17
Maggio I, Goncalves MAFV (2015) Genome editing at the crossroads of delivery, specificity, and fidelity. Trends Biotechnol 33:280–291
Gang SS, Castelletto ML, Bryant AS, Yang E, Mancuso N, Lopez JB, Pellegrini M, Hallem EA (2017) Targeted mutagenesis in a human-parasitic nematode. PLoS Pathog 13:e1006675
Peng D, Kurup SP, Yao PY, Minning TA, Tarleton RL (2015) CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi. mBio 6:e02097
Shen B, Brown KM, Lee TD, Sibley LD (2014) Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. mBio 5:e01114-14
Zhang C, Xiao B, Jiang Y, Zhao Y, Li Z, Gao H, Ling Y, Wei J, Li S, Lu M, Su X, Cui H, Yuan J (2014) Efficient editing of malaria parasite genome using the CRISPR/Cas9 system. mBio 5:e01414-14
Zhang WW, Matlashewski G (2015) CRISPR-Cas9-mediated genome editing in Leishmania donovani. mBio 6:e00861
Clark JD, Billington K, Bumstead JM, Oakes RD, Soon PE, Sopp P, Tomley FM, Blake DP (2008) A toolbox facilitating stable transfection of Eimeria species. Mol Biochem Parasitol 162:77–86
Yan W, Liu X, Shi T, Hao L, Tomley FM, Suo X (2009) Stable transfection of Eimeria tenella: constitutive expression of the YFP-YFP molecule throughout the life cycle. Int J Parasitol 39:109–117
Mali P, Yang LH, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826
Tang X, Liu X, Tao G, Qin M, Yin G, Suo J, Suo X (2016) “Self-cleaving” 2A peptide from porcine teschovirus-1 mediates cleavage of dual fluorescent proteins in transgenic Eimeria tenella. Vet Res 47:68
Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343:80–84
Huang X, Zou J, Xu H, Ding Y, Yin G, Liu X, Suo X (2011) Transgenic Eimeria tenella expressing enhanced yellow fluorescent frotein targeted to different cellular compartments stimulated dichotomic immune responses in chickens. J Immunol 187:3595–3602
Hanig S, Entzeroth R, Kurth M (2012) Chimeric fluorescent reporter as a tool for generation of transgenic Eimeria (Apicomplexa, Coccidia) strains with stage specific reporter gene expression. Parasitol Int 61:391–398
Donald RGK, Roos DS (1995) Insertional mutagenesis and marker rescue in a protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from Toxoplasmagondii. Proc Natl Acad Sci U S A 92:5749–5753
Roos DS, Sullivan WJ, Striepen B, Bohne W, Donald RGK (1997) Tagging genes and trapping promoters in Toxoplasma gondii by insertional mutagenesis. Methods 13:112–122
Chen CC, Fenk LA, de Bono M (2013) Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination. Nucleic Acids Res 41:e193
Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J, Haass C, Schmid B (2013) Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development 140:4982–4987
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823
Liu X, Shi T, Ren H, Su H, Yan W, Suo X (2008) Restriction enzyme-mediated transfection improved transfection efficiency in vitro in Apicomplexan parasite Eimeria tenella. Mol Biochem Parasites 161:72–75
Fox BA, Ristuccia JG, Gigley JP, Bzik DJ (2009) Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryot Cell 8:520–529
We thank Dr Bang Shen (Huazhong Agricultural University) for providing the plasmid of pSAG1::CAS9-U6-sgRNA(UPRT) which we used for SpCas9 and scaffold RNA amplification and for E. tenella U6 promoter analysis. We also thank the Flow Cytometry Core at National Center for Protein Sciences at Peking University, particularly Ms. Hongxia Lv and Ms. Liying Du, for technical help. We thank Dr Dongyou Liu (Royal College of Pathologists of Australasia, Australia) for efforts in improving the presentation and readability of the manuscript. This study was supported by the National Key Research and Development Program of China (2016YFD0501300), the National Natural Science Foundation of China (31873007 and 31902295), Beijing Natural Science Foundation (6204045) and the China Postdoctoral Science Foundation (2018M641566).
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tang, X., Suo, J., Liang, L. et al. Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system. Vet Res 51, 41 (2020). https://doi.org/10.1186/s13567-020-00766-0